Drawing for SDP ONCOLOGY

USPTO serial 79295445

SDP ONCOLOGY

Reviewed by CopyMark Law Group

Reg. 6331240Status 404
Filing date
Status date
Registration date
Apr 27, 2021
Examiner
ONUOHA, UKACHUKWU FREDERICK
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SDP ONCOLOGY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Anti-cancer preparations; pharmaceutical preparations for the diagnosis, prevention and treatment of cancer; biological preparations for the treatment of cancerSECTION 70 - CANCELLED
042Testing, inspection or research of pharmaceuticals; testing, inspection or research of pharmaceuticals for the diagnosis, prevention and treatment of cancerSECTION 70 - CANCELLED
044Providing medical information; providing information in the field of cancer prevention, screening, diagnosis and treatment; health care services for treating cancerSECTION 70 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 21, 2024DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Jan 21, 2024DETHDEATH OF INTERNATIONAL REGISTRATION
Aug 29, 2021FINVFINAL DECISION TRANSACTION PROCESSED BY IB
Aug 12, 2021FICSFINAL DISPOSITION NOTICE SENT TO IB
Aug 12, 2021FIMPFINAL DISPOSITION PROCESSED
Jul 27, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 27, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 9, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 9, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 20, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 6, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jan 6, 2021XAECEXAMINER'S AMENDMENT ENTERED
Jan 6, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 6, 2021GNEAEXAMINERS AMENDMENT E-MAILED
Jan 6, 2021CNEAEXAMINERS AMENDMENT -WRITTEN
Dec 17, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Dec 16, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 16, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 7, 2020RFNTREFUSAL PROCESSED BY IB
Nov 16, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 16, 2020RFRRREFUSAL PROCESSED BY MPU
Oct 29, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 28, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 24, 2020MAFRAPPLICATION FILING RECEIPT MAILED
Oct 20, 2020DOCKASSIGNED TO EXAMINER
Oct 20, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 16, 2020LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED
Oct 8, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance